Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-05-06 @ 9:46 AM
Study NCT ID:
NCT00304460
Status:
COMPLETED
Last Update Posted:
2019-12-12
First Post:
2006-03-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
060115
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None